Aquino Clinical Service is categorized under Services (Unclassified) in Bourbonnais, IL and active since 2010.
Aquino Clinical Service was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 6241100 by the NAICS.
If you are seeking more information, feel free to contact Carlos Aquino at the company’s single location by writing to 1511 North Convent St # 700, Bourbonnais, Illinois IL 60914 or by phoning (815) 304-4652. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Aquino Clinical Service |
Contact Person: | Carlos Aquino |
Address: | 1511 North Convent St # 700, Bourbonnais, Illinois 60914 |
Phone Number: | (815) 304-4652 |
Website Address: | aquinoclinicalservices.com |
Annual Revenue (USD): | Unknown |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Services (Unclassified) |
SIC Code: | 8999 |
NAICS Code: | 6241100 |
Share This Business: |
Aquino Clinical Service was started in 2010 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 6241100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Carlos Aquino for inquiries that concern Aquino Clinical Service by calling the company number (815) 304-4652, as your correspondence is most welcome. Additionally, the physical location of the single location of Aquino Clinical Service can be found at the coordinates 41.18012,-87.875671 as well as the street address 1511 North Convent St # 700 in Bourbonnais, Illinois 60914.
For its online presence, you may visit Aquino Clinical Service’s website at aquinoclinicalservices.com and engage with its social media outlets through on Twitter and on Facebook.